This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ibex Biosciences, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Roy Feinson: Innovator in Cancer Detection and Treatment
Introduction
Roy Feinson is a notable inventor based in Cumberland, MD (US). He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on developing methods for detecting and treating human cancer, particularly breast cancer.
Latest Patents
Roy Feinson holds 1 patent titled "Antibodies and therapeutic uses thereof." This patent discloses antibodies that are useful in methods for detecting and treating human cancer. Notably, it teaches novel antibodies that are effective for detecting and treating human breast cancer. In some embodiments, the patent describes antibodies that bind to filamin A, and in others, it discusses the use of intrabodies.
Career Highlights
Feinson is associated with Ibex Biosciences, Inc., where he continues to advance his research in the field of therapeutic antibodies. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Roy Feinson has collaborated with notable colleagues, including Michael Joseph Karlin and Alberto Murat Croci. These collaborations enhance the research efforts at Ibex Biosciences, Inc. and contribute to the development of innovative cancer therapies.
Conclusion
Roy Feinson's contributions to cancer research through his patented antibodies exemplify the importance of innovation in medical science. His work not only advances the understanding of cancer detection and treatment but also holds promise for future therapeutic applications.